{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T16:26:40Z","timestamp":1790526400581,"version":"4.1.0"},"reference-count":25,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.3892\/or.2017.5945","type":"journal-article","created":{"date-parts":[[2017,9,7]],"date-time":"2017-09-07T06:46:46Z","timestamp":1504766806000},"page":"3114-3120","source":"Crossref","is-referenced-by-count":18,"title":["The antitumor effects of arsenic trioxide in mantle cell lymphoma via targeting Wnt\/\u03b2-catenin pathway and DNA methyltransferase-1"],"prefix":"10.3892","volume":"38","author":[{"given":"Xin-Yu","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2017,9,7]]},"reference":[{"key":"key20180110114407_b1-or-38-05-3114","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.bbrc.2015.06.145","article-title":"The STAT3 inhibitor WP1066 synergizes with vorinostat to induce apoptosis of mantle cell lymphoma cells","volume":"464","author":"Lu","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180110114407_b2-or-38-05-3114","doi-asserted-by":"crossref","first-page":"5171","DOI":"10.1182\/blood-2008-02-139212","article-title":"Constitutive activation of the Wnt canonical pathway in mantle cell lymphoma","volume":"112","author":"Gelebart","year":"2008","journal-title":"Blood"},{"key":"key20180110114407_b3-or-38-05-3114","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1126\/science.1218370","article-title":"Wnt\/\u03b2-catenin signaling regulates telomerase in stem cells and cancer cells","volume":"336","author":"Hoffmeyer","year":"2012","journal-title":"Science"},{"key":"key20180110114407_b4-or-38-05-3114","doi-asserted-by":"crossref","first-page":"44422","DOI":"10.18632\/oncotarget.6251","article-title":"Epigenetic silencing of tumor suppressor miR-3151 contributes to Chinese chronic lymphocytic leukemia by constitutive activation of MADD\/ERK and PIK3R2\/AKT signaling pathways","volume":"6","author":"Wang","year":"2015","journal-title":"Oncotarget"},{"key":"key20180110114407_b5-or-38-05-3114","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.ccell.2016.09.014","article-title":"Decoding the DNA methylome of mantle cell lymphoma in the light of the entire B cell lineage","volume":"30","author":"Queir\u00f3s","year":"2016","journal-title":"Cancer Cell"},{"key":"key20180110114407_b6-or-38-05-3114","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1182\/blood-2014-01-552067","article-title":"Somatic mutation as a mechanism of Wnt\/\u03b2-catenin pathway activation in CLL","volume":"124","author":"Wang","year":"2014","journal-title":"Blood"},{"key":"key20180110114407_b7-or-38-05-3114","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.3892\/or.2016.5161","article-title":"Survivin T34A increases the therapeutic efficacy of arsenic trioxide in mouse hepatocellular carcinoma models","volume":"36","author":"Huang","year":"2016","journal-title":"Oncol Rep"},{"key":"key20180110114407_b8-or-38-05-3114","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1002\/cncr.29852","article-title":"The evolution of arsenic in the treatment of acute promyelocytic leukemia and other myeloid neoplasms: Moving toward an effective oral, outpatient therapy","volume":"122","author":"Falchi","year":"2016","journal-title":"Cancer"},{"key":"key20180110114407_b9-or-38-05-3114","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1300874","article-title":"Gruppo Italiano Malattie Ematologiche dell'Adulto; German-Austrian Acute Myeloid Leukemia Study Group; Study Alliance Leukemia: Retinoic acid and arsenic trioxide for acute promyelocytic leukemia","volume":"369","author":"Lo-Coco","year":"2013","journal-title":"N Engl J Med"},{"key":"key20180110114407_b10-or-38-05-3114","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1007\/s00277-014-2124-y","article-title":"Adding ascorbic acid to arsenic trioxide produces limited benefit in patients with acute myeloid leukemia excluding acute promyelocytic leukemia","volume":"93","author":"Aldoss","year":"2014","journal-title":"Ann Hematol"},{"key":"key20180110114407_b11-or-38-05-3114","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1182\/blood-2014-11-611459","article-title":"Arsenic trioxide and all-trans retinoic acid target NPM1 mutant oncoprotein levels and induce apoptosis in NPM1-mutated AML cells","volume":"125","author":"Martelli","year":"2015","journal-title":"Blood"},{"key":"key20180110114407_b12-or-38-05-3114","doi-asserted-by":"crossref","first-page":"3968","DOI":"10.1002\/cncr.26741","article-title":"A phase 2 trial of combination therapy with thalidomide, arsenic trioxide, dexamethasone, and ascorbic acid (TADA) in patients with overlap myelodysplastic\/myeloproliferative neoplasms (MDS\/MPN) or primary myelofibrosis (PMF)","volume":"118","author":"Bejanyan","year":"2012","journal-title":"Cancer"},{"key":"key20180110114407_b13-or-38-05-3114","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1002\/cncr.26517","article-title":"A randomized phase 2 trial of a preparative regimen of bortezomib, high-dose melphalan, arsenic trioxide, and ascorbic acid","volume":"118","author":"Sharma","year":"2012","journal-title":"Cancer"},{"key":"key20180110114407_b14-or-38-05-3114","first-page":"857","article-title":"ESMO Consensus conferences: guidelines on malignant lymphoma","volume":"2","author":"Dreyling","year":"2013","journal-title":"part"},{"key":"key20180110114407_b15-or-38-05-3114","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bbrc.2015.11.071","article-title":"Arsenic trioxide suppresses cell growth and migration via inhibition of miR-27a in breast cancer cells","volume":"469","author":"Zhang","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180110114407_b16-or-38-05-3114","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.1039\/C5NR07860A","article-title":"A facile route to core-shell nanoparticulate formation of arsenic trioxide for effective solid tumor treatment","volume":"8","author":"Zhang","year":"2016","journal-title":"Nanoscale"},{"key":"key20180110114407_b17-or-38-05-3114","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1172\/JCI14064","article-title":"Arsenic inhibition of telomerase transcription leads to genetic instability","volume":"108","author":"Chou","year":"2001","journal-title":"J Clin Invest"},{"key":"key20180110114407_b18-or-38-05-3114","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1182\/blood.V96.4.1525","article-title":"Arsenic trioxide induces dose- and time-dependent apoptosis of endothelium and may exert an antileukemic effect via inhibition of angiogenesis","volume":"96","author":"Roboz","year":"2000","journal-title":"Blood"},{"key":"key20180110114407_b19-or-38-05-3114","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/j.leukres.2008.03.039","article-title":"Arsenic trioxide and 2-methoxyestradiol reduce beta-catenin accumulation after proteasome inhibition and enhance the sensitivity of myeloma cells to Bortezomib","volume":"32","author":"Zhou","year":"2008","journal-title":"Leuk Res"},{"key":"key20180110114407_b20-or-38-05-3114","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1182\/blood-2014-12-613703","article-title":"Downregulation of the Wnt inhibitor CXXC5 predicts a better prognosis in acute myeloid leukemia","volume":"125","author":"K\u00fchnl","year":"2015","journal-title":"Blood"},{"key":"key20180110114407_b21-or-38-05-3114","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13045-015-0161-1","article-title":"Targeting Wnt pathway in mantle cell lymphoma-initiating cells","volume":"8","author":"Mathur","year":"2015","journal-title":"J Hematol Oncol"},{"key":"key20180110114407_b22-or-38-05-3114","first-page":"885","article-title":"Arsenic trioxide inhibits viability and induces apoptosis through reactivating the Wnt inhibitor secreted frizzled related protein-1 in prostate cancer cells","volume":"9","author":"Zheng","year":"2016","journal-title":"Onco Targets Ther"},{"key":"key20180110114407_b23-or-38-05-3114","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1182\/blood.V97.5.1172","article-title":"Expression of DNA methyltransferases DNMT1, 3A, and 3B in normal hematopoiesis and in acute and chronic myelogenous leukemia","volume":"97","author":"Mizuno","year":"2001","journal-title":"Blood"},{"key":"key20180110114407_b24-or-38-05-3114","unstructured":"HaasBWFilkowskiMMCochranRNDenisonLIshakANishitaniSSmithAKEpigenetic modification of OXT and human sociabilityProc Natl Acad Sci USA113E3816E3823201610.1073\/pnas.1602809113273257574941462"},{"key":"key20180110114407_b25-or-38-05-3114","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1002\/jcb.24838","article-title":"Metabolism of arsenic trioxide in acute promyelocytic leukemia cells","volume":"115","author":"Khaleghian","year":"2014","journal-title":"J Cell Biochem"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","deposited":{"date-parts":[[2020,10,17]],"date-time":"2020-10-17T02:27:17Z","timestamp":1602901637000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2017.5945"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,7]]},"references-count":25,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,9,7]]},"published-print":{"date-parts":[[2017,11]]}},"alternative-id":["10.3892\/or.2017.5945"],"URL":"https:\/\/doi.org\/10.3892\/or.2017.5945","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,7]]}}}